DAM Capital has reiterated its buy rating on Laurus Labs with a target price of ₹1,083 per share after a solid Q2FY26 performance that beat consensus estimates. The brokerage said the company reported strong earnings, with EBITDA in line with expectations and supported by CDMO traction and robust gross margins.
DAM Capital noted that Laurus’ balance sheet strengthened further as net debt reduced, aided by healthy operating cash flows and improved working capital management. The brokerage expects the company to continue delivering margin expansion, supported by operational efficiency and better product mix.
The firm highlighted that Laurus maintained guidance for achieving 1.1x asset turns in the near term and sees further margin upside as high-value CDMO projects scale up. DAM Capital believes Laurus’ growth momentum will remain strong, backed by continued improvement in profitability metrics and disciplined capital deployment.
Disclaimer: The views and recommendations above are those of DAM Capital. Business Upturn does not endorse them. Please consult a financial advisor before making investment decisions.
